Sort
48,018 grants matching “immunotherapy”
Bioinformatics Technology to Characterize Tumor Infiltrating Immune Repertoires
$423,633Heng Li · Dana-Farber Cancer Inst · U01 · FY2020 · CA
Modulating Immunity through Dendritic Cell Phagocytic Receptors
$423,541Nina Bhardwaj · New York University School Of Medicine · R01 · FY2008 · AI
Project 2
$423,518David A Barbie · Dana-Farber Cancer Inst · P50 · FY2025 · CA
Pathological Mechanisms of Immune-Mediated Cerebellar Ataxia with Associated Sez6L2 Autoantibodies
$423,500Jennetta W Hammond · University Of Rochester · R21 · FY2022 · NS
Defining Mechanisms of Cognitive Dysfunction in Central Nervous System Autoimmunity
$423,500May Htwe Han · Stanford University · R21 · FY2025 · NS
ELUCIDATION & MODULATION OF NATURAL KILLER CELL SIGNALING: APPLICATION IN CANCER
$423,497Michael A Caligiuri · Ohio State University · P01 · FY2010 · CA
Dissecting the immunological mechanisms associated with prostate cancer progression in African-American men and exploring epigenetics-based immune modulation for therapy
$423,486Dennis O Adeegbe · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2021 · CA
[18F]-AraG -PET imaging to evaluate immunological response to checkpoint inhibitor therapy (CKI) in patients with advanced solid tumors
$423,444Shivaani Kummar · Stanford University · R01 · FY2020 · CA
Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma
$423,426Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2024 · CA
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
$423,409Benjamin Aaron Alman · Duke University · R01 · FY2015 · CA
Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK Cells
$423,402Jianhua Yu · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Screening for Compounds that Lower Intracellular Alpha-Synuclein Levels
$423,400Varghese John · University Of California Los Angeles · R21 · FY2021 · AG
Mechanisms of immunotherapy response and resistance in pancreatic ductal adenocarcinoma
$423,354Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2022 · CA
Mechanisms of immunotherapy response and resistance in pancreatic ductal adenocarcinoma
$423,354Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2023 · CA
Project 3: Adaptive immunity to MCPyV in Merkel cell carcinoma
$423,325David M Koelle · University Of Washington · P01 · FY2023 · CA
Mechanisms of the Induction of Oral Tolerance
$423,324Howard L Weiner · Brigham And Women'S Hospital · R01 · FY2011 · AI
Metabolism-based interactions and organ-targeted delivery of molnupiravir, nirmatrelvir and remdesivir
$423,312Bingfang Yan · University Of Cincinnati · R01 · FY2023 · AI
Impact of Genetic Diversity on Human Xenograft Tumor Growth
$423,300Muneer Gulamhusein Hasham · Jackson Laboratory · R33 · FY2021 · CA
Impact of Genetic Diversity on Human Xenograft Tumor Growth
$423,298Muneer Gulamhusein Hasham · Jackson Laboratory · R33 · FY2020 · CA
Isoprenylcysteine Carboxyl Methyltransferase (ICMT) as a Target in NRAS Driven Melanoma - Resubmission - 1
$423,242Mark Reid Philips · New York University School Of Medicine · R01 · FY2019 · CA
Isoprenylcysteine Carboxyl Methyltransferase (ICMT) as a Target in NRAS Driven Melanoma - Resubmission - 1
$423,242Mark Reid Philips · New York University School Of Medicine · R01 · FY2020 · CA
Combinational Immunotherapy Targeting the Melanoma-Associated Vasculature
$423,186Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · CA
Combinational Immunotherapy Targeting the Melanoma-Associated Vasculature
$423,186Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · CA
Defining therapeutic strategies for boosting T-cell infiltration into cold tumors with spatial proteomics and machine learning
$423,078Matthew W. Thomson · California Institute Of Technology · R21 · FY2023 · CA
Mechanisms of Immune-mediated Tumor Cell Destruction
$423,078Thomas Sayers · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA